News

July 30, 2009 – A new study comparing nephrotoxicity of the iso-osmolar contrast medium iodixanol to low-osmolar contrast media (LOCM) found iodixanol shows no reduction in contrast-induced acute kidney injury (CI-AKI) compared to some agents, which may prompt the ACC and AHA to change their current guidelines.

Home July 30, 2009
Home
News

July 29, 2009 – Medtronic Inc. said earlier this week it has reached a settlement with Abbott Laboratories over intellectual property litigation regarding stent design and stent delivery systems.

Home July 29, 2009
Home
News

July 29, 2009 – CircuLite Inc. said today it was awarded a Fast-Track Phase I-II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to fund the development of a pediatric circulatory assist device based upon CircuLite’s Synergy Pocket Micro-pump.

Home July 29, 2009
Home
News

July 29, 2009 – Transoma Medical Inc., manufacturer of Sleuth AT wireless implantable cardiac monitoring system, today announced the first patient enrollment and implant in a long-term study to monitor patients who have been prescribed catheter ablation therapy for atrial fibrillation (AF) at risk of recurrence of AF after the procedure.

Home July 29, 2009
Home
News

July 29, 2009 – The Society of Nuclear Medicine (SNM) and a coalition of eight other organizations have issued a white paper urging Congress to take steps to maintain adequate supplies of molybdenum-99 (Mo-99), a radioactive substance that is the basis for a common medical isotope used in more than 80 percent of all nuclear medicine procedures.

Home July 29, 2009
Home
News

July 28, 2009 – Bioheart Inc. today said the FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure.

Home July 28, 2009
Home
News

July 28, 2009 – Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in the United States.

Home July 28, 2009
Home
News

July 28, 2009 – Onset Medical Corporation said today it received CE mark approval to begin marketing the SoloPath Endovascular Access Catheter in the European Union.

Home July 28, 2009
Home
News

July 28, 2009 – The American College of Cardiology (ACC) is taking a leading role in healthcare reform in partnership with patients, lawmakers and payers. The ACC said it is setting a new standard for healthcare delivery, one that centers on increasing the quality of care and ensuring greater patient access and value.

Home July 28, 2009
Home
News

July 28, 2009 – Researchers may be able to predict future severe cardiac events in patients with known, stable coronary artery disease (CAD) using coronary calcium scoring, according to a study published today in the online edition of Radiology.

Home July 28, 2009
Home
News

July 27, 2009 - TeraRecon Inc., a leader in advanced visualization and decision support solutions for medical imaging and a partner of the Society of Cardiovascular Computed Tomography (SCCT), and Agfa HealthCare released the first cardiac CT review and reporting solution which conforms to the SCCT’s published guidelines* for cardiac CT interpretation.

Home July 27, 2009
Home
News

July 27, 2009 – Prescient Medical Inc. received the prestigious 2009 North American Product Innovation of the Year Award from Frost & Sullivan for Atherosclerosis Lesion Management, for its efforts to reduce deaths related to heart attacks using the vProtect Luminal Shield.

Home July 27, 2009
Home
News

July 27, 2009 – Terumo Cardiovascular Systems said Friday it initiated a phase II clinical trial for the Anaconda AAA (abdominal aortic aneurysm) stent graft system in the U.S.

Home July 27, 2009
Home
Technology

July 27, 2009 – Carestream Health Inc. today launched a new Web-based cardiology PACS that offers a single integrated platform for diagnosis, image review and reporting for echocardiography, cardiac catheterization and nuclear cardiology procedures as well as electrocardiogram management.

Home July 27, 2009
Home
News

July 24, 2009 – Michael Jones has become the world’s first recipient of adult cardiac stem cells to treat congestive heart failure. Jones’ infusion on July 17 marks the world’s first phase-one, FDA-approved clinical trial using c-kit-positive cardiac stem cells to treat heart disease being conducted by a team of University of Louisville physicians at Jewish Hospital.

Home July 24, 2009
Home
Subscribe Now